These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5453003)

  • 1. [Combined rifampicin-ethambutol therapy of resistent pulmonary tuberculosis. Effectiveness of various rifampicin doses in combination with ethambutol].
    Hetrick C; Ras R; Turri M
    Dtsch Med Wochenschr; 1970 Sep; 95(36):1830-3. PubMed ID: 5453003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1971 Sep; 46(9):371-7. PubMed ID: 4330662
    [No Abstract]   [Full Text] [Related]  

  • 3. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.
    Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4620294
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampicin with ethambutol for drug-resistant tuberculosis.
    Pines A
    Br J Dis Chest; 1971 Jul; 65():178-81. PubMed ID: 4997816
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
    Zierski M; Bek E; Kucharska A; Graczyk J; Bukalska Z
    Gruzlica; 1973 Nov; 41(11):1129-37. PubMed ID: 4765793
    [No Abstract]   [Full Text] [Related]  

  • 7. Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
    Verbist L; Mbete S; Van Landuyt H; Darras T; Gyselen A
    Chest; 1972 Jun; 61(6):555-63. PubMed ID: 4624278
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary results with rifampicin in the treatment of drug-resistant tuberculosis.
    Pines A
    Tubercle; 1969 Mar; 50():Suppl:50-2. PubMed ID: 5402545
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of pyrazinamide combined with rifampicin and ethambutol in animal experiments].
    Tynystanova RI; Kozlova NV
    Probl Tuberk; 1984 Jul; (7):59-63. PubMed ID: 6483843
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination therapy of pulmonary tuberculosis using rifampicin and ethambutol].
    Haegi V
    Helv Med Acta Suppl; 1969; 49():81-7. PubMed ID: 5267584
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistance].
    Baba H; Takahashi R; Azuma Y
    Kekkaku; 1971 Nov; 46(11):429-35. PubMed ID: 5004056
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.
    Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4283482
    [No Abstract]   [Full Text] [Related]  

  • 14. A trial of intermittent rifampicin and ethambutol in retreatment regimens.
    Zierski M
    Scand J Respir Dis Suppl; 1973; 84():132-5. PubMed ID: 4522067
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 17. Analytical study of the treatment of 18 cases of chronic open pulmonary tuberculosis with secondary resistance to rifampicin.
    Lukas W
    Respiration; 1971; 28():Suppl:70-83. PubMed ID: 5150796
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of 100 pulmonary tubercular patients whose bacilli are resistant to streptomycin, isoniazid and ethionamid, with a combination of rifampicin and ethambutol. Comparison between 2 dosages of rifampicin (weekly treatment for 4 months, biweekly for 8 months after)].
    Hétrick G; Muñoz I; Ras R
    Rev Tuberc Pneumol (Paris); 1970; 34(5):715-6. PubMed ID: 5496795
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative clinical evaluation of the treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin by the daily and intermittent methods].
    Zierski M; Bek E; Bergson H; Kucharska A; Strupczewska-Janusz H
    Pneumonol Pol; 1977 Apr; 45(4):277-90. PubMed ID: 854460
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
    Jeanes CW; Jessamine AG; Eidus L
    Can Med Assoc J; 1972 Apr; 106(8):884-8. PubMed ID: 4623743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.